Blackdot Appoints New Health Science Practice Lead to Support Growing Client Base

Blackdot is excited to announce the appointment of former AstraZeneca Head of Commercial Excellence for ANZ David Manifold to lead the company’s new health science division.

The appointment comes as Blackdot aims to bolster its health science offering and service a growing list of global clients from across the sector.

Since Blackdot’s inception in 2011, the health science sector has been a mainstay for the company’s client portfolio. Leading organisations across the sector form a large proportion of Blackdot’s consulting and benchmarking work, with the company developing four unique benchmarking solutions specifically for health science organisations.

Commencing at Blackdot on the 4th of October, David brings over 16 years’ dedicated health science experience, having served in multiple senior positions at AstraZeneca and Sanofi Pasteur. In his most recent role at AstraZeneca, David led the company’s commercial excellence capabilities across the Australian and New Zealand markets, driving growth across digital channels, market research, patient innovation, sales force effectiveness, as well as sales and brand capabilities development.

Commenting on his appointment to Blackdot, David Manifold said:

As a long-time client of Blackdot I’ve been able to see the real power of their methodology, in particular the focus that their benchmarking process can bring to highly targeted capability and consulting solutions. It’s great to be joining such a dynamic and growing team and it’s a genuinely exciting opportunity to be able to leverage my health science experience to support Blackdot’s growing health science client base.”

Contact: To learn more about Blackdot’s new health science division, please contact chris.horn@theblackdot.com.au.